Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Gradishar

Showing results (101-110 of 195) with videos related to

Pageof 20
Sort By:
Clinical Breast Cancer|October 27, 2024
Effective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient CareHeather N Moore, Marcus D Goncalves, Abigail M Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2012
A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancerWilliam J Gradishar, Virginia Kaklamani, Tarini P Sahoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004George Somlo, Francesco Atzori, Lewis C Strauss, et al.
The Breast Journal|May 20, 2003
A roundtable discussion of aromatase inhibitors as therapy for breast cancerD Craig Allred, Michael Baum, Aman U Buzdar, et al.
Clinical Breast Cancer|July 9, 2005
Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancerRuth M O'Regan, Jamie H Von Roenn, Robert W Carlson, et al.
Breast Cancer Research and Treatment|January 4, 2021
Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservationMolly B Moravek, Rafael Confino, Angela K Lawson, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 27, 2014
Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapyAndrew C Gordon, William J Gradishar, Virginia G Kaklamani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingJulia R Trosman, Christine B Weldon, William J Gradishar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Burnout and career satisfaction among US oncologistsTait D Shanafelt, William J Gradishar, Michael Kosty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
Satisfaction with work-life balance and the career and retirement plans of US oncologistsTait D Shanafelt, Marilyn Raymond, Michael Kosty, et al.
Pageof 20

Showing results (101-110 of 195) with videos related to

Sort By:
Pageof 20
Clinical Breast Cancer|October 27, 2024
Effective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient CareHeather N Moore, Marcus D Goncalves, Abigail M Johnston, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2012
A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancerWilliam J Gradishar, Virginia Kaklamani, Tarini P Sahoo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004George Somlo, Francesco Atzori, Lewis C Strauss, et al.
The Breast Journal|May 20, 2003
A roundtable discussion of aromatase inhibitors as therapy for breast cancerD Craig Allred, Michael Baum, Aman U Buzdar, et al.
Clinical Breast Cancer|July 9, 2005
Final results of a phase II trial of preoperative TAC (docetaxel/doxorubicin/cyclophosphamide) in stage III breast cancerRuth M O'Regan, Jamie H Von Roenn, Robert W Carlson, et al.
Breast Cancer Research and Treatment|January 4, 2021
Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservationMolly B Moravek, Rafael Confino, Angela K Lawson, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 27, 2014
Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapyAndrew C Gordon, William J Gradishar, Virginia G Kaklamani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 19, 2018
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingJulia R Trosman, Christine B Weldon, William J Gradishar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 29, 2014
Burnout and career satisfaction among US oncologistsTait D Shanafelt, William J Gradishar, Michael Kosty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
Satisfaction with work-life balance and the career and retirement plans of US oncologistsTait D Shanafelt, Marilyn Raymond, Michael Kosty, et al.
Pageof 20